Discover
MBX
MBX Biosciences, Inc.
55.92
2 x 41.73
2 x 70.65
bid
ask
+
0.72
1.30%
2 @ 04:00 PM
56.43 +0.51 (0.91%)
| Ytd | 77.30% | |
| 1y | 381.65% |
55.05
day range
58.50
9.63
52 week range
58.50
| Open | 55.20 | Prev Close | 55.20 | Low | 55.05 | High | 58.50 | Mkt Cap | 2.66B |
| Vol | 1.05M | Avg Vol | 759.30K | EPS | -2.17 | P/E | N/A | Forward P/E | -14.03 |
| Beta | N/A | Short Ratio | 7.25 | Inst. Own | 116.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 35.99 | 200-d Avg | 30.14 | 1yr Est | 69.09 |
| Income Statement | |||
| Operating Expenses | 27.27M | ||
| Research and Development Expense | 18.47M | ||
| Selling, General and Administrative Expense | 8.79M | ||
| Operating Income | -27.26M | ||
| Net Income | -23.52M | ||
| Net Income Common Stock | -23.52M | ||
| Net Income Common Stock (USD) | -23.52M | ||
| Consolidated Income | -23.52M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -23.52M | ||
| Earning Before Interest & Taxes (USD) | -23.52M | ||
| Weighted Average Shares | 46.58M | ||
| Weighted Average Shares Diluted | 46.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 45.21M | ||
| Cash and Equivalents (USD) | 45.21M | ||
| Investments | 394.76M | ||
| Investments Current | 394.76M | ||
| Current Assets | 448.54M | ||
| Property, Plant & Equipment Net | 3.59M | ||
| Total Assets | 452.70M | ||
| Debt Current | 178.00K | ||
| Total Debt | 555.00K | ||
| Current Liabilities | 14.57M | ||
| Debt Non-Current | 377.00K | ||
| Total Liabilities | 14.95M | ||
| Accumulated Retained Earnings (Deficit) | -247.99M | ||
| Accumulated Other Comprehensive Income | -606.00K | ||
| Shareholders Equity | 437.76M | ||
| Shareholders Equity (USD) | 437.76M | ||
| Assets Non-Current | 4.17M | ||
| Total Debt (USD) | 555.00K | ||
| Liabilities Non-Current | 378.00K | ||
| Trade and Non-Trade Payables | 6.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 98.00K | ||
| Net Cash Flow from Financing | 87.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -29.87M | ||
| Capital Expenditure | -437.00K | ||
| Issuance (Purchase) of Equity Shares | 87.81M | ||
| Net Cash Flow from Investing | -97.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -96.66M | ||
| Net Cash Flow from Operations | -20.21M | ||
| Share Based Compensation | 5.48M | ||